Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P15088 (
mast cell
)
14,925
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SERPINB6
(PI6) is a member of the intracellular serine protease inhibitors (serpins). Previous studies showed that
SERPINB6
is localized mainly in the cytoplasm of endothelial cells, some epithelial cells, monocytes, and neutrophils. In these cells
SERPINB6
is thought to prevent cellular damage by scavenging leaking lysosomal proteases. We show here, using novel, well-defined monoclonal antibodies, that
SERPINB6
is abundantly expressed by mast cells in all organs and by the human
mast cell
line HMC-1. Gel filtration experiments revealed that the latter cells contain a high-molecular-weight form of
SERPINB6
, which consists of sodium dodecyl sulfate (SDS)-stable complexes of this inhibitor with monomeric beta-tryptase. Expression of
SERPINB6
by mast cells was compared with those of tryptase and CD117 (c-kit) in biopsies from patients with different forms of
mast cell
disease. In all cases the lesional mast cells expressed
SERPINB6
, and, in diffuse cutaneous mastocytosis and mastocytoma,
SERPINB6
was expressed by a substantially higher number of mast cells when compared with tryptase. In conclusion,
SERPINB6
is abundantly expressed by normal mast cells and by mast cells in mastocytoma lesions. We suggest that in mast cells,
SERPINB6
serves to regulate the activity of endogenous beta-tryptase in the cytoplasm.
...
PMID:Intracellular serpin SERPINB6 (PI6) is abundantly expressed by human mast cells and forms complexes with beta-tryptase monomers. 1467 Sep 19